SPC
TMO icon

Spirepoint Private Client’s Thermo Fisher Scientific TMO Stock Holding History

Spirepoint Private Client’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Sell
2,755
-16,570
-86% -$7.95M 0.11% 105
2026
Q1 		$9.5M Buy
19,325
+6,484
+50% +$3.52M 0.9% 32
2025
Q4 		$7.44M Buy
12,841
+1,263
+11% +$714K 0.71% 41
2025
Q3 		$5.62M Buy
11,578
+95
+0.8% +$44.2K 0.59% 49
2025
Q2 		$4.66M Buy
11,483
+272
+2% +$114K 0.53% 56
2025
Q1 		$5.58M Buy
11,211
+668
+6% +$362K 0.73% 43
2024
Q4 		$5.48M Buy
10,543
+511
+5% +$281K 0.69% 43
2024
Q3 		$6.21M Buy
10,032
+347
+4% +$205K 0.82% 33
2024
Q2 		$5.36M Buy
9,685
+379
+4% +$217K 0.76% 32
2024
Q1 		$5.41M Buy
+9,306
New +$5.22M 0.82% 30

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Spirepoint Private Client's TMO Position: Q2 2026 in Review

Spirepoint Private Client reduced its Thermo Fisher Scientific (TMO) stake by 86% in Q2 2026, selling an estimated $7.95M and leaving 2,755 shares worth $1.38M. The position accounts for 0.11% of the portfolio, ranked #105.

Spirepoint Private Client first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.5M in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Spirepoint Private Client held 2,755 shares of Thermo Fisher Scientific worth $1.38M as of Q2 2026.
  • Spirepoint Private Client sold 16,570 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.95M.
  • Thermo Fisher Scientific made up 0.11% of Spirepoint Private Client's portfolio in Q2 2026, its #105 holding.
  • Spirepoint Private Client first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
  • Spirepoint Private Client's Thermo Fisher Scientific position peaked at $9.5M in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.